222 related articles for article (PubMed ID: 24220012)
21. Nuclear cytomorphometry in feline mammary gland epithelial tumours.
Simeonov R; Simeonova G
Vet J; 2009 Feb; 179(2):296-300. PubMed ID: 17959399
[TBL] [Abstract][Full Text] [Related]
22. Expression of Stat3 in feline mammary gland tumours and its relation to histological grade.
Petterino C; Ratto A; Arcicasa E; Podestà G; Drigo M; Pellegrino C
Vet Res Commun; 2006 Aug; 30(6):599-611. PubMed ID: 16838202
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.
Mills SW; Musil KM; Davies JL; Hendrick S; Duncan C; Jackson ML; Kidney B; Philibert H; Wobeser BK; Simko E
Vet Pathol; 2015 Mar; 52(2):238-49. PubMed ID: 25060990
[TBL] [Abstract][Full Text] [Related]
24. Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?
Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD; Klopfleisch R
J Proteome Res; 2011 Oct; 10(10):4405-15. PubMed ID: 21888431
[TBL] [Abstract][Full Text] [Related]
25. Prognostic histopathological and molecular markers in feline mammary neoplasia.
Hughes K; Dobson JM
Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma.
Pisamai S; Rungsipipat A; Kunnasut N; Suriyaphol G
J Comp Pathol; 2017; 157(2-3):150-162. PubMed ID: 28942298
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas.
Ivanyi D; Minke JM; Hageman C; Groeneveld E; van Doornewaard G; Misdorp W
Am J Vet Res; 1993 Jul; 54(7):1095-102. PubMed ID: 7690208
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
[TBL] [Abstract][Full Text] [Related]
30. Mammary mucinous carcinoma in the cat.
Sarli G; Brunetti B; Benazzi C
Vet Pathol; 2006 Sep; 43(5):667-73. PubMed ID: 16966443
[TBL] [Abstract][Full Text] [Related]
31. Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content.
Seixas F; Palmeira C; Pires MA; Lopes C
Vet Pathol; 2007 Nov; 44(6):842-8. PubMed ID: 18039897
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours.
Petterino C; Podestà G; Ratto A; Drigo M; Pellegrino C
Vet Res Commun; 2007 Feb; 31(2):173-84. PubMed ID: 17186410
[TBL] [Abstract][Full Text] [Related]
33. HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray-Fluorescence In Situ Hydridization-Based Study.
Muscatello LV; Di Oto E; Sarli G; Monti V; Foschini MP; Benazzi C; Brunetti B
Vet Pathol; 2019 Mar; 56(2):230-238. PubMed ID: 30384816
[TBL] [Abstract][Full Text] [Related]
34. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
35. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of claudin-1 is related with malignancy in canine thyroid tumors.
Flores AR; Rêma A; Amorim I; Gartner F
In Vivo; 2015; 29(1):23-8. PubMed ID: 25600525
[TBL] [Abstract][Full Text] [Related]
38. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
39. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]